Mitomycin

丝裂霉素

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameMitomycin
Drug Alias Namemitomycine丝裂酶素自力霉素Mitomycin Cmitomicina +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsTissue AdhesionsUrinary Bladder Diseases +[39] 
Global Approved IndicationsGlaucomaEye DiseasesUrinary Bladder Neoplasms +[15] 
Approved Indications in ChinaLung NeoplasmsOvarian NeoplasmsPancreatic Neoplasms +[8] 
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin Co LtdEgymedicalpediaSpectrum Health Corp +[12] 
Inactive CompaniesPro Top & Mediking Company LtdVan Andel Research InstituteUniversity Of California San Francisco +[20] 
Active IndicationsGastroesophageal Junction NeoplasmsGlaucomaPterygium +[20] 
Inactive IndicationsTissue AdhesionsUrinary Bladder DiseasesKidney Failure, Chronic +[19] 

Other Information

ATC CodeL01DC03
Related LinksWikipediaDrugBankKEGG